Market Overview The global Brugada syndrome market was valued at USD 1.37 billion in 2022 and is expected to grow at a CAGR of 5.7% during the forecast period.  Brugada Syndrome (BrS) is a rare genetic disorder affecting the heart's electrical system, leading to arrhythmias and an increased risk of sudden cardiac death. The global market for Brugada Syndrome is experiencing significant...